Abstract

In the patient presenting with an elevated blood count who does not have an acquired clonal disorder causing a myeloproliferative neoplasm, hereditary erythrocytosis or hereditary thrombocytosis needs to be considered as a possible explanation. A young patient and/or those with a family history of myeloproliferative neoplasm should specifically raise this possibility. Among the causes of hereditary erythrocytosis are mutations in the genes in the oxygen sensing pathway and high-affinity hemoglobins. Hereditary thrombocytosis has been shown to be accounted for by mutations in THPO, MPL, and JAK2 genes. In those who have a possible hereditary erythrocytosis or thrombocytosis, the investigative pathway includes specific investigation to rule out the more common acquired clonal disorders, and, if indicated, other secondary causes, measurement of specific cytokines as indicated, and search for specific identified molecular lesions that have been shown to cause these hereditary disorders. There remain individuals who appear to have a hereditary disorder in whom a genetic lesion cannot currently be identified.

References

References
1.
Johansson
PL
,
Safai-Kutti
S
,
Kutti
J
.
An elevated venous haemoglobin concentration cannot be used as a surrogate marker for absolute erythrocytosis: a study of patients with polycythaemia vera and apparent polycythaemia
.
Br J Haematol
.
2005
;
129
(
5
):
701
-
705
.
2.
Rumi
E
,
Passamonti
F
,
Della Porta
MG
, et al
.
Familial chronic myeloproliferative disorders: clinical phenotype and evidence of disease anticipation
.
J Clin Oncol
.
2007
;
25
(
35
):
5630
-
5635
.
3.
Jones
AV
,
Chase
A
,
Silver
RT
, et al
.
JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms
.
Nat Genet
.
2009
;
41
(
4
):
446
-
449
.
4.
Oddsson
A
,
Kristinsson
SY
,
Helgason
H
, et al
.
The germline sequence variant rs2736100_C in TERT associates with myeloproliferative neoplasms
.
Leukemia
.
2014
;
28
(
6
):
1371
-
1374
.
5.
Jäger
R
,
Harutyunyan
AS
,
Rumi
E
, et al
.
Common germline variation at the TERT locus contributes to familial clustering of myeloproliferative neoplasms
.
Am J Hematol
.
2014
;
89
(
12
):
1107
-
1110
.
6.
Tapper
W
,
Jones
AV
,
Kralovics
R
, et al
.
Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms
.
Nat Commun
.
2015
;
6
(
6691
):
6691
.
7.
Hinds
DA
,
Barnholt
KE
,
Mesa
RA
, et al
.
Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms
.
Blood
.
2016
;
128
(
8
):
1121
-
1128
.
8.
Saliba
J
,
Saint-Martin
C
,
Di Stefano
A
, et al
.
Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies
.
Nat Genet
.
2015
;
47
(
10
):
1131
-
1140
.
9.
Harutyunyan
AS
,
Giambruno
R
,
Krendl
C
, et al
.
Germline RBBP6 mutations in familial myeloproliferative neoplasms
.
Blood
.
2016
;
127
(
3
):
362
-
365
.
10.
Arber
DA
,
Orazi
A
,
Hasserjian
R
, et al
.
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
.
Blood
.
2016
;
127
(
20
):
2391
-
2405
.
11.
Barbui
T
,
Thiele
J
,
Carobbio
A
, et al
.
Discriminating between essential thrombocythemia and masked polycythemia vera in JAK2 mutated patients
.
Am J Hematol
.
2014
;
89
(
6
):
588
-
590
.
12.
McMullin
MF
,
Harrison
CN
,
Ali
S
, et al
;
BSH Committee
.
A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology Guideline
.
Br J Haematol
.
2019
;
184
(
2
):
176
-
191
.
13.
de la Chapelle
A
,
Träskelin
A-L
,
Juvonen
E
.
Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis
.
Proc Natl Acad Sci USA
.
1993
;
90
(
10
):
4495
-
4499
.
14.
Bento
C
,
Percy
MJ
,
Gardie
B
, et al
;
ECE-Consortium
.
Genetic basis of congenital erythrocytosis: mutation update and online databases
.
Hum Mutat
.
2014
;
35
(
1
):
15
-
26
.
15.
McMullin
MF
,
Cario
H
.
LNK mutations and myeloproliferative disorders
.
Am J Hematol
.
2016
;
91
(
2
):
248
-
251
.
16.
Ang
SO
,
Chen
H
,
Hirota
K
, et al
.
Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia
.
Nat Genet
.
2002
;
32
(
4
):
614
-
621
.
17.
Lenglet
M
,
Robriquet
F
,
Schwarz
K
, et al
.
Identification of a new VHL exon and complex splicing alterations in familial erythrocytosis or von Hippel-Lindau disease
.
Blood
.
2018
;
132
(
5
):
469
-
483
.
18.
Percy
MJ
,
Zhao
Q
,
Flores
A
, et al
.
A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis
.
Proc Natl Acad Sci USA
.
2006
;
103
(
3
):
654
-
659
.
19.
Arsenault
PR
,
Pei
F
,
Lee
R
, et al
.
A knock-in mouse model of human PHD2 gene-associated erythrocytosis establishes a haploinsufficiency mechanism
.
J Biol Chem
.
2013
;
288
(
47
):
33571
-
33584
.
20.
Ladroue
C
,
Carcenac
R
,
Leporrier
M
, et al
.
PHD2 mutation and congenital erythrocytosis with paraganglioma
.
N Engl J Med
.
2008
;
359
(
25
):
2685
-
2692
.
21.
Percy
MJ
,
Furlow
PW
,
Lucas
GS
, et al
.
A gain-of-function mutation in the HIF2A gene in familial erythrocytosis
.
N Engl J Med
.
2008
;
358
(
2
):
162
-
168
.
22.
Zmajkovic
J
,
Lundberg
P
,
Nienhold
R
, et al
.
A gain-of-function mutation in EPO in familial erythrocytosis
.
N Engl J Med
.
2018
;
378
(
10
):
924
-
930
.
23.
Percy
MJ
,
Butt
NN
,
Crotty
GM
, et al
.
Identification of high oxygen affinity hemoglobin variants in the investigation of patients with erythrocytosis
.
Haematologica
.
2009
;
94
(
9
):
1321
-
1322
.
24.
Percy
MJ
,
Lappin
TR
.
Recessive congenital methaemoglobinaemia: cytochrome b(5) reductase deficiency
.
Br J Haematol
.
2008
;
141
(
3
):
298
-
308
.
25.
Rosa
R
,
Prehu
MO
,
Beuzard
Y
,
Rosa
J
.
The first case of a complete deficiency of diphosphoglycerate mutase in human erythrocytes
.
J Clin Invest
.
1978
;
62
(
5
):
907
-
915
.
26.
Tuschl
K
,
Clayton
PT
,
Gospe
SM
Jr
, et al
.
Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man [published correction appears in Am J Hum Genet. 2016;99(2):521]
.
Am J Hum Genet
.
2012
;
90
(
3
):
457
-
466
.
27.
Beutler
E
,
Westwood
B
,
van Zwieten
R
,
Roos
D
.
G→T transition at cDNA nt 110 (K37Q) in the PKLR (pyruvate kinase) gene is the molecular basis of a case of hereditary increase of red blood cell ATP
.
Hum Mutat
.
1997
;
9
(
3
):
282
-
285
.
28.
Ghilardi
N
,
Wiestner
A
,
Kikuchi
M
,
Ohsaka
A
,
Skoda
RC
.
Hereditary thrombocythaemia in a Japanese family is caused by a novel point mutation in the thrombopoietin gene
.
Br J Haematol
.
1999
;
107
(
2
):
310
-
316
.
29.
Graziano
C
,
Carone
S
,
Panza
E
, et al
.
Association of hereditary thrombocythemia and distal limb defects with a thrombopoietin gene mutation
.
Blood
.
2009
;
114
(
8
):
1655
-
1657
.
30.
Moliterno
AR
,
Williams
DM
,
Gutierrez-Alamillo
LI
,
Salvatori
R
,
Ingersoll
RG
,
Spivak
JL
.
Mpl Baltimore: a thrombopoietin receptor polymorphism associated with thrombocytosis
.
Proc Natl Acad Sci USA
.
2004
;
101
(
31
):
11444
-
11447
.
31.
Teofili
L
,
Giona
F
,
Torti
L
, et al
.
Hereditary thrombocytosis caused by MPLSer505Asn is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis
.
Haematologica
.
2010
;
95
(
1
):
65
-
70
.
32.
El-Harith
HA
,
Roesl
C
,
Ballmaier
M
, et al
.
Familial thrombocytosis caused by the novel germ-line mutation p.Pro106Leu in the MPL gene
.
Br J Haematol
.
2009
;
144
(
2
):
185
-
194
.
33.
Bellanné-Chantelot
C
,
Mosca
M
,
Marty
C
,
Favier
R
,
Vainchenker
W
,
Plo
I
.
Identification of MPL R102P mutation in hereditary thrombocytosis
.
Front Endocrinol (Lausanne)
.
2017
;
8
(
235
):
235
.
34.
Mead
AJ
,
Chowdhury
O
,
Pecquet
C
, et al
.
Impact of isolated germline JAK2V617I mutation on human hematopoiesis
.
Blood
.
2013
;
121
(
20
):
4156
-
4165
.
35.
Etheridge
SL
,
Cosgrove
ME
,
Sangkhae
V
, et al
.
A novel activating, germline JAK2 mutation, JAK2R564Q, causes familial essential thrombocytosis
.
Blood
.
2014
;
123
(
7
):
1059
-
1068
.
36.
Rumi
E
,
Harutyunyan
AS
,
Casetti
I
, et al
.
A novel germline JAK2 mutation in familial myeloproliferative neoplasms
.
Am J Hematol
.
2014
;
89
(
1
):
117
-
118
.
37.
Marty
C
,
Saint-Martin
C
,
Pecquet
C
, et al
.
Germ-line JAK2 mutations in the kinase domain are responsible for hereditary thrombocytosis and are resistant to JAK2 and HSP90 inhibitors
.
Blood
.
2014
;
123
(
9
):
1372
-
1383
.
38.
Kapralova
K
,
Horvathova
M
,
Pecquet
C
, et al
.
Cooperation of germ line JAK2 mutations E846D and R1063H in hereditary erythrocytosis with megakaryocytic atypia
.
Blood
.
2016
;
128
(
10
):
1418
-
1423
.
39.
Camps
C
,
Petousi
N
,
Bento
C
, et al
;
WGS500 Consortium
.
Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations
.
Haematologica
.
2016
;
101
(
11
):
1306
-
1318
.
40.
Petousi
N
,
Copley
RR
,
Lappin
TR
, et al
;
WGS Consortium
.
Erythrocytosis associated with a novel missense mutation in the BPGM gene
.
Haematologica
.
2014
;
99
(
10
):
e201
-
e204
.
You do not currently have access to this content.

Comments

0 Comments